Bicycle Therapeutics plc (BCYC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bicycle Therapeutics plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.24x | -4.82x | -3.56x | -7.79x | -22.83x | -6.74x |
| P/B Ratio | 0.80x | 1.03x | 1.73x | 3.24x | 4.41x | 3.60x |
| P/S Ratio | 6.76x | 23.10x | 23.85x | 60.70x | 130.42x | 33.08x |
| Profitability | ||||||
| Gross Margin | 100.0% | -390.3% | -480.1% | 100.0% | 100.0% | -219.0% |
| Operating Margin | -341.3% | -595.0% | -704.1% | -806.6% | -561.0% | -500.1% |
| Net Margin | -301.7% | -479.2% | -669.7% | -779.3% | -571.2% | -491.0% |
| EBITDA Margin | -292.3% | -467.4% | -679.9% | -741.3% | -547.9% | -487.8% |
| Liquidity | ||||||
| Current Ratio | 11.02x | 13.81x | 8.08x | 6.92x | 12.65x | 6.73x |
| Quick Ratio | 11.02x | 13.81x | 8.08x | 6.92x | 12.65x | 6.73x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.01x | 0.12x | 0.16x | 0.13x | 0.17x |
YoY = year-over-year change. Source: FMP..